𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy

✍ Scribed by E. Martinelli; R. De Palma; M. Orditura; F. De Vita; F. Ciardiello

Book ID
108701084
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
317 KB
Volume
158
Category
Article
ISSN
0009-9104

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Anti-epidermal growth factor receptor-an
Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer
✍ Christine Solbach; Marc Roller; Andre Ahr; Sibylle Loibl; Maria Nicoletti; Manfr πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 118 KB πŸ‘ 1 views

Recent studies demonstrated that tumors overexpressing the epidermal growth factor receptor (EGF-R, erbB-1) are associated with poor clinical outcome. This led to the development of a variety of monoclonal antibodies targeting the extracellular domain of this receptor tyrosine kinase. The aim of our

A monoclonal antibody to the human epide
A monoclonal antibody to the human epidermal growth factor receptor
✍ Michael D. Waterfield; Elaine L. V. Mayes; Paul Stroobant; Paul L. P. Bennet; Su πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 844 KB

## Abstract A monoclonal antibody of the IgG class, EGFR1, has been isolated using cells of the epidermoid carcinoma line A431 as immunogen. The A431 antigen recognized by EGFR1 has an apparent molecular weight of approximately 175,000, is a cell‐surface molecule which can be specifically cross‐lin